<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anal Bioanal Chem</journal-id><journal-title-group><journal-title>Analytical and Bioanalytical Chemistry</journal-title></journal-title-group><issn pub-type="ppub">1618-2642</issn><issn pub-type="epub">1618-2650</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21479793</article-id><article-id pub-id-type="pmc">3098365</article-id><article-id pub-id-type="publisher-id">4895</article-id><article-id pub-id-type="doi">10.1007/s00216-011-4895-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Semi-quantitative analyses of metabolic systems of human colon cancer metastatic xenografts in livers of superimmunodeficient NOG mice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kubo</surname><given-names>Akiko</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ohmura</surname><given-names>Mitsuyo</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wakui</surname><given-names>Masatoshi</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Harada</surname><given-names>Takahiro</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kajihara</surname><given-names>Shigeki</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Ogawa</surname><given-names>Kiyoshi</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Suemizu</surname><given-names>Hiroshi</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Nakamura</surname><given-names>Masato</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Setou</surname><given-names>Mitsutoshi</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Suematsu</surname><given-names>Makoto</given-names></name><address><phone>+81-3-53633753</phone><fax>+81-3-53633466</fax><email>msuem@sc.itc.keio.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Department of Biochemistry, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160&#x02013;8582 Japan </aff><aff id="Aff2"><label>2</label>Japan Science and Technology Agency (JST), Exploratory Research for Advanced Technology (ERATO) Suematsu Gas Biology Project, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160&#x02013;8582 Japan </aff><aff id="Aff3"><label>3</label>Department of Laboratory Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160&#x02013;8582 Japan </aff><aff id="Aff4"><label>4</label>Technology Research Laboratory, Shimadzu Corporation, 3-9-4 Hikaridai, Seika-cho, Soraku-gun, Kyoto, 619&#x02013;0237 Japan </aff><aff id="Aff5"><label>5</label>Central Institute for Experimental Animals, 1430 Nogawa, Miyamae-ku, Kawasaki-shi, Kanagawa, 216&#x02013;0001 Japan </aff><aff id="Aff6"><label>6</label>Department of Pathology and Regenerative Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara-shi, Kanagawa, 259&#x02013;1193 Japan </aff><aff id="Aff7"><label>7</label>Department of Molecular Anatomy, Molecular Imaging Frontier Research Center, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu-shi, Shizuoka, 431&#x02013;3192 Japan </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>4</month><year>2011</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>4</month><year>2011</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2011</year></pub-date><volume>400</volume><issue>7</issue><fpage>1895</fpage><lpage>1904</lpage><history><date date-type="received"><day>29</day><month>11</month><year>2010</year></date><date date-type="rev-recd"><day>7</day><month>2</month><year>2011</year></date><date date-type="accepted"><day>9</day><month>3</month><year>2011</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2011</copyright-statement></permissions><abstract id="Abs1"><p>Analyses of energy metabolism in human cancer have been difficult because of rapid turnover of the metabolites and difficulties in reducing time for collecting clinical samples under surgical procedures. Utilization of xenograft transplantation of human-derived colon cancer HCT116 cells in spleens of superimmunodeficient NOD/SCID/IL-2R&#x003b3;<sup>null</sup> (NOG) mice led us to establish an experimental model of hepatic micrometastasis of the solid tumor, whereby analyses of the tissue sections collected by snap-frozen procedures through newly developed microscopic imaging mass spectrometry (MIMS) revealed distinct spatial distribution of a variety of metabolites. To perform intergroup comparison of the signal intensities of metabolites among different tissue sections collected from mice in fed states, we combined matrix-assisted laser desorption/ionization time-of-flight imaging mass spectrometry (MALDI&#x02013;TOF-IMS) and capillary electrophoresis&#x02013;mass spectrometry (CE&#x02013;MS), to determine the apparent contents of individual metabolites in serial tissue sections. The results indicated significant elevation of ATP and energy charge in both metastases and the parenchyma of the tumor-bearing livers. To note were significant increases in UDP-<italic>N</italic>-acetyl hexosamines, and reduced and oxidized forms of glutathione in the metastatic foci versus the liver parenchyma. These findings thus provided a potentially important method for characterizing the properties of metabolic systems of human-derived cancer and the host tissues in vivo.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1007/s00216-011-4895-5) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Imaging mass spectrometry (IMS)</kwd><kwd>Matrix-assisted laser desorption/ionization (MALDI)</kwd><kwd>Capillary electrophoresis&#x02013;mass spectrometry (CE&#x02013;MS)</kwd><kwd>Tumor-bearing liver</kwd><kwd>Metabolome</kwd><kwd>Glycoprotein biosynthesis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2011</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Imaging mass spectrometry (IMS) has enabled us to collect spatial information about a variety of biomolecules, for example phospholipids [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], drugs [<xref ref-type="bibr" rid="CR3">3</xref>], peptides [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>], and metabolites [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>] in tissue sections in situ. Many kinds of ion sources for imaging mass spectrometry had been developed in recent years. For example, ultraviolet matrix-assisted laser desorption/ionization (MALDI) is capable of producing ions from low-molecular-mass compounds, being promising for imaging volatile compounds in fresh ginger samples [<xref ref-type="bibr" rid="CR9">9</xref>]. Low-molecular-mass metabolites have also been analyzed by other methods including desorption electrospray ionization and desorption/ionization on silicon [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. In these methods, samples should be dried before image acquisition of metabolomic snapshots to avoid enzymatic degradation of the molecule of interest. On the other hand, laser ablation electrospray ionization or infrared MALDI are other useful methods of molecular imaging that are applicable to water-rich specimens to ionize the analytes [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p>In order to acquire reliable images of metabolites in and around cancers in vivo, several lines of methodological consideration are necessary. First, enzymatic reactions in tissue and cell samples should be terminated as soon as possible. Second, soft ionization of the molecules seemed desirable to identify individual peaks of metabolites. Finally, high spatial resolution at cellular levels is required to examine differences in metabolic properties between the cancer foci and the surrounding host tissues. In this context, application of ultraviolet MALDI to freeze-dried tissue samples is suitable for examining cancer metabolism in vivo. Regarding the spatial resolution of the ultraviolet MALDI, the raster scan pitch of the laser application has been restricted by its focusing diameter, in the approximate range 50&#x02013;200&#x000a0;&#x003bc;m [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Our newly developed UV&#x02013;MALDI&#x02013;quadrupole ion-trap (QIT)-TOF-MS instrument, that is, a mass microscope with 10-&#x003bc;m spatial resolution, overcame this problem of spatial resolution by improvement of the ion source to control the position of the sample stage three-dimensionally with high accuracy [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Using 9-aminoacridine as a matrix, metabolites, such as high-energy nucleotides and phosphorylated carbohydrates became directly detectable in frozen tissue sections [<xref ref-type="bibr" rid="CR6">6</xref>]. Since then, various types of tissues including brain and muscles of mice have been analyzed experimentally to dissect molecular mechanisms for metabolic systems in vivo [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].</p><p>The objective of this study was to characterize metabolic systems in and around human-derived solid tumors in vivo. Although distinct properties of cancer metabolism known as Warburg effects have been examined mainly in cultured systems or conventional animal experiments, there are several technical difficulties in characterizing the metabolism of human solid tumors in vivo. First, it is difficult to shorten the time for sampling of tissues to avoid degradation of metabolites with rapid turnover under surgical procedures. Second, because of large variances of the mass intensities of molecules among individual tissue samples, a method to semi-quantify their signals and to compare these among individual samples should be developed. To overcome the first problem, we have herein utilized an experimental model of xenograft transplantation of human-derived colon cancer HCT 116 cell line in superimmunodeficient NOD/SCID/IL-2R&#x003b3;<sup>null</sup> (NOG) mice [<xref ref-type="bibr" rid="CR17">17</xref>]. In this model, we were able to collect snap-frozen samples of the tumor-bearing liver for analyses by using imaging mass spectrometry with high spatial resolution. To solve the second problem, we used serial sections of the liver to determine total amounts of individual metabolites, using CE&#x02013;MS for data calibration. This method enabled us to carry out intergroup comparison of semi-quantitative metabolite data in and around micrometastases of the human-derived colon cancer. Results obtained in this study revealed that the tumor-bearing liver accelerates its energy metabolism. Furthermore, several metabolites including UDP-<italic>N</italic>-acetyl hexosamine (UDP-HexNAc) and glutathione, and the value of energy charge were significantly elevated in the metastatic foci, suggesting significance of these molecules as marker metabolites enriched in the cancer in vivo.</p></sec><sec id="Sec2"><title>Experimental</title><sec id="Sec3"><title>Chemicals</title><p>9-Aminoacridine (9-AA) was purchased from Merck Schuchardt (Hohenbrunn, Germany). All chemical standards were obtained from common commercial sources and dissolved in Milli-Q (Millipore) water, 0.1&#x000a0;mol&#x000a0;L<sup>&#x02212;1</sup> HCl, or 0.1&#x000a0;mol&#x000a0;L<sup>&#x02212;1</sup> NaOH to furnish 10&#x000a0;mmol&#x000a0;L<sup>&#x02212;1</sup> or 100&#x000a0;mmol&#x000a0;L<sup>&#x02212;1</sup> stock solutions. Distilled water purified by use of a Milli-Q water system was used for all the preparations. Working standard mixtures were prepared by diluting stock solutions with Milli-Q water immediately before injection of samples for CE&#x02013;MS analysis. The chemicals used were analytical or reagent grades.</p></sec><sec id="Sec4"><title>Animal model to observe growth of human-derived cancer in vivo</title><p>Care and use of laboratory animals were in accordance with the Experimental Animal Committee of Keio University School of Medicine which followed the Guidelines for the Proper Conduct of Animal Experiments by the Science Council of Japan. We herein applied an experimental model using superimmunodeficient NOD/SCID/IL-2R&#x003b3;<sup>null</sup> (NOG) mice [<xref ref-type="bibr" rid="CR18">18</xref>] which lack T-cells, B-cells, and NK cells, enabling xenograft transplantation of the human-derived colon cancer cell line HCT116 transfected with <italic>venus</italic>, a GFP-mutant gene (HCT116/<italic>venus</italic>) was injected intrasplenically as described elsewhere [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. To our knowledge, the system using NOG mice serves as a reliable experimental model in which human-derived cancer cell lines transplanted in vivo generate metastases forming solid tumors in organs including the liver in vivo with greater reproducibility than the conventional model using NOD mice which lack T-cells and B-cells but not NK cells [<xref ref-type="bibr" rid="CR17">17</xref>]. In the intrasplenic implantation model using HCT116/<italic>venus</italic>, micrometastases of the cancer occurred mostly in periportal regions of the liver within one week, extending their size over the following three weeks [<xref ref-type="bibr" rid="CR19">19</xref>]. In this study, male mice at 11&#x02013;13&#x000a0;weeks were fed with Laboratory chow and allowed free access to water. They were anesthetized by use of pentobarbital sodium, and their abdominal walls were cut to exteriorize the portion of the liver lobules for snap-frozen procedures using liquid nitrogen as described elsewhere [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. The livers of the xenograft-transplanted NOG mice used for the analyses were collected under fed conditions two weeks after the xenograft transplantation, unless otherwise mentioned.</p></sec><sec id="Sec5"><title>Tissue preparation</title><p>A schematic diagram of a standard experimental design typical of tissue section application can be seen in the Electronic Supplementary Material (Fig. S<xref rid="MOESM1" ref-type="">1</xref>). The liver tissues snap-frozen in liquid nitrogen were dissected to prepare cryosections with 5-&#x003bc;m thickness by use of a cryostat (CM 1900; Leica Microsystems, Wetzlar, Germany). The sections were thaw-mounted on indium&#x02013;tin oxide (ITO) slides (8&#x02013;12 ohm/sq; Sigma, Chiba, Japan) and were dried in silica gel-containing plastic tubes then sprayed with 9-aminoacridine (9-AA, 20&#x000a0;mg in 4&#x000a0;mL 70% MeOH) by use of a 0.2-mm nozzle caliber airbrush (Procon boy FWA Platinum; Mr Hobby, Tokyo, Japan) to conduct MALDI&#x02013;IMS in negative ion mode. Adjacent sections were fixed with 10% buffered formalin (Nacalai Tesque, Kyoto, Japan) and stained with the Masson trichrome staining reagent kit according to the manufacturer&#x02019;s procedures (Muto Pure Chemicals, Tokyo, Japan). The other frozen tissues were used for metabolome analyses using CE&#x02013;MS.</p></sec><sec id="Sec6"><title>Instruments</title><p>An atmospheric pressure MALDI&#x02013;QIT-TOF-MS equipped with a 355-nm Nd:YAG laser and a built-in fluorescence microscope furnished mass images with high spatial resolution of 10&#x000a0;&#x003bc;m, as described for a prototype IMS machine [<xref ref-type="bibr" rid="CR9">9</xref>] (Mass Microscope; Shimadzu, Kyoto, Japan). The microscope was also equipped with a 120-W metal halide light source (X-Cite 120PC-Q; Lumen Dynamics Group, Ontario, Canada) and a fluorescence mirror unit (U-MGFPHQ; Olympus, Tokyo, Japan) that enabled us to visualize <italic>venus</italic>-associated green fluorescence from metastatic foci in tissue slices before matrix application. This system thus enabled us to collect both fluorescence images and mass images from the same tissue slices. Before applying matrices, a fluorescence image of the analyte was acquired and followed by recording the location of the specimen on the <italic>XYZ</italic> stage. ITO slides with the sample holder were removed from the <italic>XYZ</italic> stage, and sprayed uniformly with 4&#x000a0;mL 9-AA solution. After application of the matrix, the sample holder was placed back on the <italic>XYZ</italic> stage, which was adjusted to exactly the same location. The mass spectra of the designated areas on a specimen photographed before matrix application were acquired in the negative-ion mode. The data collected through the microscopic system were digitally processed according to the method described later, in the section &#x0201c;<italic>Determination of the apparent contents of metabolites based on data calibration by CE&#x02013;MS</italic>&#x0201d;. Experiments using capillary electrophoresis electrospray ionization mass spectrometry (CE&#x02013;MS) were performed with a capillary electrophoresis system equipped with an air pressure pump, MSD quadrupole MS, isocratic HPLC pump, and CE&#x02013;MS adapter kit (Agilent Technologies, Waldbronn, Germany) [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. All system control, data acquisition, and MSD data evaluation were performed using Agilent G2201A ChemStation software for CE&#x02013;MSD.</p></sec><sec id="Sec7"><title>Conditions for MALDI imaging and tandem MS analyses</title><p>All the MALDI imaging experiments and tandem MS experiments were carried out in negative-ion mode using a prototype mass microscope. The laser power was adjusted to the desired intensities. MALDI mass spectra were acquired under the conditions laser frequency 800&#x000a0;Hz and scanning mass range from <italic>m</italic>/<italic>z</italic> 260 to <italic>m</italic>/<italic>z</italic> 900. Regions of the tissue samples exposed to the laser irradiation were determined by light and fluorescence microscopic observations. A raster scan on the tissue surface was performed automatically (250&#x02009;&#x000d7;&#x02009;250 spots per scan). Laser irradiation was repeated 160 times for the individual spots. The spatial interval of data points was 10&#x000a0;&#x003bc;m, giving 62,500 data points in total for each section. Tandem MS analyses were performed to determine the structures of metabolites at appropriate laser energy, argon gas percentage, and collision-induced dissociation (CID) energy conditions. To identify metabolites detected in MALDI&#x02013;IMS, we searched the Human Metabolome Database (<ext-link ext-link-type="uri" xlink:href="http://hmdb.ca">http://hmdb.ca</ext-link>) and performed tandem MS analyses, comparing the tandem mass spectra with those from standard reagents using 9-AA as the matrix of choice in negative mode. The distribution of biomolecules that were identifies by MS<sup>2</sup> analysis were visualized as mass images using BioMap software (<ext-link ext-link-type="uri" xlink:href="http://www.maldi-msi.org">http://www.maldi-msi.org</ext-link>) from Novartis (Basel, Switzerland).</p></sec><sec id="Sec8"><title>Determination of the apparent contents of metabolites based on data calibration by CE&#x02013;MS</title><p>To compare differences in contents of many different metabolites in multiple tissue slices collected from different subjects, we conducted CE&#x02013;MS-based metabolome analyses of tissue lysates collected from the same snap-frozen liver samples for IMS. As reported previously [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>], CE&#x02013;MS enabled us to quantitatively determine more than 2,000 different metabolites at once in small amounts of a single liver sample. Small amounts of the frozen tissue were collected from thick section that was adjacent to the section for IMS. The CE&#x02013;MS samples weighing approximately 300&#x000a0;mg wet weight was ground using a multi-bead shocker (model MB755U; Yasui Kikai, Osaka, Japan) with frozen metal granules, and 1&#x000a0;mL methanol containing internal standards (300&#x000a0;&#x003bc;mol&#x000a0;L<sup>&#x02212;1</sup> each of <sc>l</sc>-methionine sulfone and 2-morpholinoethanesulfonic acid (MES)) was added. After addition of 0.5&#x000a0;mL deionized water and 1&#x000a0;mL chloroform, the mixture was centrifuged at 15,000&#x000a0;rpm for 15&#x000a0;min at 4&#x000a0;&#x000b0;C. The upper aqueous layer of the sample was filtered through the 5-kDa cutoff filter (Millipore, Tokyo, Japan) by centrifugation to remove protein components. The filtrate was lyophilized and dissolved in 200&#x000a0;&#x003bc;L deionized water containing reference compounds (200&#x000a0;&#x003bc;mol&#x000a0;L<sup>&#x02212;1</sup> each of 3-aminopyrrolidine and trimesate). The amounts of metabolites were normalized by liver weight of the original tissue samples. Assuming that 1&#x000a0;mg wet tissue was equivalent to 1&#x000a0;&#x003bc;L, apparent contents of individual metabolites were calculated for the data calibration in imaging mass microscopy by computer-assisted data processing in the later session.</p><p>To semi-quantify apparent contents of individual metabolites mapped on the images, regions of interest (ROIs) for the cancer xenografts and the liver parenchyma were selected by careful visual inspection of fluorescence and light microscopic images. Averaged spectra from each ROI were generated and statistically analyzed by use of the laboratory-written software SIMtools (Shimadzu Imaging Mass spectrometry toolbox for MATLAB). The Mann&#x02013;Whitney U-test was used to compare the ion signal intensity between the tumor and the liver parenchyma.</p><p>To calculate apparent contents of metabolites in IMS, mass signals covering <italic>m</italic>/<italic>z</italic> between 260 and 620 were collected from 250&#x02009;&#x000d7;&#x02009;250 spots on a tissue sample. Direct comparison of metabolite ion signals among different slices requires realistic transformation of acquired mass signals of a metabolite in absolute terms, for example tissue contents in nmol&#x000a0;g<sup>&#x02212;1</sup> tissue. To that effect, apparent contents of a specific metabolite in the ROI designated as liver parenchyma ([<italic>C</italic><sub>Liver</sub>]<sub>app</sub> ) or tumor ([<italic>C</italic><sub>Tumor</sub>]<sub>app</sub> ) were calculated by use of Eqs.&#x000a0;<xref rid="Equ1" ref-type="">1</xref>, <xref rid="Equ2" ref-type="">2</xref>, and <xref rid="Equ3" ref-type="">3</xref>:
<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\left[ {{C_{\text{Tumor}}}} \right]_{\text{app}}} = \left[ {{C_{\text{Average}}}} \right] \times \left( {{I_{\text{Tumor}}}/{I_{\text{Average}}}} \right) $$\end{document}</tex-math><graphic xlink:href="216_2011_4895_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M2">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\left[ {{C_{\text{Liver}}}} \right]_{\text{app}}} = \left[ {{C_{\text{Average}}}} \right] \times \left( {{I_{\text{Liver}}}/{I_{\text{Average}}}} \right) $$\end{document}</tex-math><graphic xlink:href="216_2011_4895_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {I_{\text{Average}}} = \left( {{I_{\text{Liver}}} \times {O_{\text{Liver}}}} \right)/100 + \left( {{I_{\text{Tumor}}} \times {O_{\text{Tumor}}}} \right)/100 $$\end{document}</tex-math><graphic xlink:href="216_2011_4895_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula>where [<italic>C</italic><sub>Average</sub>] denotes the amount of a metabolite of interest in the whole tissue section for IMS (nmol&#x000a0;g<sup>&#x02212;1</sup> tissue). <italic>I</italic><sub>Tumor</sub>, <italic>I</italic><sub>Liver</sub>, and <italic>I</italic><sub>Average</sub> are MALDI signal intensities measured in regions of tumor metastases, liver parenchyma, and the whole tissue section, respectively. <italic>O</italic><sub>Tumor</sub> and <italic>O</italic><sub>Liver</sub> are the percentage areas of tumor regions and liver parenchyma, respectively, in tumor-bearing livers. These indices were designated by the green fluorescence intensities acquired by fluorescence microscopy of the whole frozen section using Image J software (NIH, <ext-link ext-link-type="uri" xlink:href="http://rsbweb.nih.gov/ij/index.html">http://rsbweb.nih.gov/ij/index.html</ext-link>). Assuming that percentages of tumor-bearing regions in the tissue sections are comparable with those of the metastases in the adjacent tissue samples for the CE&#x02013;MS measurements, the values of [<italic>C</italic><sub>Average</sub>] can be replaced by [<italic>C</italic><sub>CE&#x02013;MS</sub>], the amounts of the metabolites of interest in the tissue samples for CE&#x02013;MS, as seen in Eqs.&#x000a0;<xref rid="Equ4" ref-type="">1&#x02032;</xref> and <xref rid="Equ5" ref-type="">2&#x02032;</xref>.
<disp-formula id="Equ4"><label>1&#x02032;</label><alternatives><tex-math id="M4">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\left[ {{C_{\text{Tumor}}}} \right]_{\text{app}}} = \left[ {{C_{{{\text{CE - MS}}}}}} \right] \times \left( {{I_{\text{Tumor}}}/{I_{\text{Average}}}} \right) $$\end{document}</tex-math><graphic xlink:href="216_2011_4895_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ5"><label>2&#x02032;</label><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\left[ {{C_{\text{Liver}}}} \right]_{\text{app}}} = \left[ {{C_{{{\text{CE - MS}}}}}} \right] \times \left( {{I_{\text{Liver}}}/{I_{\text{Average}}}} \right) $$\end{document}</tex-math><graphic xlink:href="216_2011_4895_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula>In order to calculate the values for [<italic>C</italic><sub>Tumor</sub>]<sub>app</sub> and [<italic>C</italic><sub>Liver</sub>]<sub>app</sub>, <italic>I</italic><sub>Tumor</sub>, <italic>I</italic><sub>Liver</sub>, and <italic>I</italic><sub>Average</sub> were determined in three different ROIs in a single tissue specimen, while the corresponding value of [<italic>C</italic><sub>CE&#x02013;MS</sub>] was collected from a portion of the tissue adjacent to the samples for IMS. A set of mass-imaging data paired with CE&#x02013;MS data in a single animal were repeated for four separate animals.</p><p>To construct an ion-content map, data collected by MALDI&#x02013;QIT-MS were saved and digitally processed to be converted to Analyze format, a common multidimensional biomedical imaging format file. The Analyze format file was processed to construct an ion-content map, where the relationship between the apparent content of a metabolite of interest at a pixel &#x0201c;<italic>i</italic>&#x0201d; (<italic>Ci</italic>) and the MALDI signal intensity in the same pixel (<italic>I</italic><sub>(<italic>i</italic>)</sub>) was expressed by Eq.&#x000a0;<xref rid="Equ6" ref-type="">4</xref>:
<disp-formula id="Equ6"><label>4</label><alternatives><tex-math id="M6">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ Ci = \left[ {{C_{{{\text{CE}} - {\text{MS}}}}}} \right] \times \left( {{I_{{(i)}}}/{I_{\text{Average}}}} \right) $$\end{document}</tex-math><graphic xlink:href="216_2011_4895_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula></p></sec><sec id="Sec9"><title>Validation of the calibrated data in IMS by analysis of high-energy adenylates in vivo</title><p>Reliability of the calibrated data seemed to depend on multiple factors including the quality of CE&#x02013;MS-based metabolome analysis and that of tissue-sampling procedures in the snap-frozen processes. In accordance with our previous studies [<xref ref-type="bibr" rid="CR7">7</xref>], we determined apparent contents of ATP, ADP, and AMP by IMS combined with CE&#x02013;MS. Based on these data, apparent energy charge of individual pixels were calculated by use of Eq.&#x000a0;<xref rid="Equ7" ref-type="">5</xref>:
<disp-formula id="Equ7"><label>5</label><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\text{Apparent}}\,{\text{energy}}\,{\text{charge}}\,\left( {E{C_{\text{app}}}} \right) = \left( {{{\left[ {\text{ATP}} \right]}_{\text{app}}} + 1/2{{\left[ {\text{ADP}} \right]}_{\text{app}}}} \right)/\left( {{{\left[ {\text{ATP}} \right]}_{\text{app}}} + {{\left[ {\text{ADP}} \right]}_{\text{app}}} + {{\left[ {\text{AMP}} \right]}_{\text{app}}}} \right) $$\end{document}</tex-math><graphic xlink:href="216_2011_4895_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula></p></sec><sec id="Sec10"><title>Statistics</title><p>Differences between mean values for two groups were statistically analyzed by use of the Mann&#x02013;Whitney <italic>U</italic>-test. <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></sec></sec><sec id="Sec11"><title>Results and discussion</title><sec id="Sec12"><title>Detection of metabolites from normal mouse liver tissue</title><p>As shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, MALDI&#x02013;MS analyses in the negative-ion mode using 9-AA as the matrix revealed the presence of many signals including nucleotides on the liver tissue frozen section with minimal interference from the matrix, as reported by Edwards and Kennedy [<xref ref-type="bibr" rid="CR6">6</xref>]. Among these peaks, 16 intense mass peaks were assigned using their exact masses to nucleotides, nucleotide-sugar conjugates, 2,3-bisphosphoglycerate (2,3-BPG), taurocholate, and both reduced and oxidized forms of glutathione. Assignment of these metabolites was verified by structural analysis of individual peaks using tandem MS. In the region adjacent to those for mass-imaging experiments in the same section, the peaks generated on the tissue surface were identified by fragmentation using MALDI&#x02013;QIT-TOF MS [<xref ref-type="bibr" rid="CR9">9</xref>]. Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> summarizes the results of MS and MS<sup>2</sup> analyses. Among the individual mass peaks of nucleoside-monophosphate, the ribose-phosphate structure was present (211.0 fragment ions and neutral losses of adenine, uridine, and guanidine from precursor ions respectively). Among the peaks of nucleotide&#x02013;sugar conjugates, fragment ions derived from the UDP structure were confirmed (403.0 fragment ions and neutral loss of each hexose, glucuronic acid, and <italic>N</italic>-acetylhexosamines). All the assigned and verified metabolites in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> were compared with commercial standard compounds under appropriate MALDI and CID tandem MS conditions.
<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Typical MALDI mass spectrum of the mouse liver collected from the &#x0201c;mass microscope&#x0201d; a MALDI&#x02013;IT-TOF analyzer in the negative-ion mode. The signals ranging from <italic>m</italic>/<italic>z</italic>&#x02009;=&#x02009;260 to 620 were collected. Mass spectra of metabolites were obtained by integrating 10,000,000 consecutive laser shots (160 shots per subspectrum and 62,500 subspectra). Peaks identified in this study are labeled; that originating from the 9-AA matrix is indicated by an <italic>asterisk</italic></p></caption><graphic xlink:href="216_2011_4895_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>List of metabolites identified in the study, with their respective deprotonated <italic>m</italic>/<italic>z</italic> values and MS<sup>2</sup> ion species in the negative mode</p></caption><table frame="hsides" rules="groups"><thead><tr><th>No.</th><th>[M-H]<sup>&#x02212;</sup> (<italic>m</italic>/<italic>z</italic>)</th><th>Fragments observed in MS<sup>2</sup></th><th>Formula</th><th>Identified</th></tr></thead><tbody><tr><td>1</td><td>264.95</td><td>246.973, 179.043, 166.955</td><td>C<sub><sc>3</sc></sub>H<sub>8</sub>O<sub>10</sub>P<sub>2</sub></td><td>2,3-Bisphosphoglycerate</td></tr><tr><td>2</td><td>306.07</td><td>254.087, 179.050, 143.048, 158.932, 210.092, 288.858, 120.041</td><td>C<sub><sc>10</sc></sub>H<sub>17</sub>N<sub>3</sub>O<sub>6</sub>S</td><td>Glutathione (GSH)</td></tr><tr><td>3</td><td>323.02</td><td>211.006, 280.028, 138.983, 158.922</td><td>C<sub><sc>9</sc></sub>H<sub>13</sub>N<sub>2</sub>O<sub>9</sub>P</td><td>UMP</td></tr><tr><td>4</td><td>403.00</td><td>304.984, 158.907, 384.935, 322.989, 290.931, 272.920</td><td>C<sub>9</sub>H<sub>14</sub>N<sub>2</sub>O<sub>12</sub>P<sub>2</sub></td><td>UDP</td></tr><tr><td>5</td><td>482.93</td><td>384.927, 272.919, 176.913, 158.905</td><td>C<sub>9</sub>H<sub>15</sub>N<sub>2</sub>O<sub>15</sub>P<sub>3</sub></td><td>UTP</td></tr><tr><td>6</td><td>346.05</td><td>211.000, 150.985, 134.049, 194.051</td><td>C<sub>10</sub>H<sub>14</sub>N<sub>5</sub>O<sub>7</sub>P</td><td>AMP</td></tr><tr><td>7</td><td>426.02</td><td>328.044, 134.053, 407.999, 329.037, 272.950, 290.945</td><td>C<sub>10</sub>H<sub>15</sub>N<sub>5</sub>O<sub>10</sub>P<sub>2</sub></td><td>ADP</td></tr><tr><td>8</td><td>505.98</td><td>408.022, 272.958, 158.922, 176.933, 392.003</td><td>C<sub>10</sub>H<sub>16</sub>N<sub>5</sub>O<sub>13</sub>P<sub>3</sub></td><td>ATP</td></tr><tr><td>9</td><td>361.98</td><td>210.985, 260.838, 158.908</td><td>C<sub>10</sub>H<sub>14</sub>N<sub>5</sub>O<sub>8</sub>P</td><td>GMP</td></tr><tr><td>10</td><td>441.96</td><td>343.992, 150.025, 158.909</td><td>C<sub>10</sub>H<sub>15</sub>N<sub>5</sub>O<sub>11</sub>P<sub>2</sub></td><td>GDP</td></tr><tr><td>11</td><td>521.91</td><td>423.940, 272.924, 176.911, 158.906, 229.979</td><td>C<sub>10</sub>H<sub>16</sub>N<sub>5</sub>O<sub>14</sub>P<sub>3</sub></td><td>GTP</td></tr><tr><td>12</td><td>565.03</td><td>323.024, 306.072, 402.984, 211.000, 384.977</td><td>C<sub><sc>15</sc></sub>H<sub>24</sub>N<sub>2</sub>O<sub>17</sub>P<sub>2</sub></td><td>UDP-glucose (UDP-Hexose)</td></tr><tr><td>13</td><td>579.02</td><td>323.027, 402.997, 254.996, 305.011, 210.994</td><td>C<sub><sc>15</sc></sub>H<sub>22</sub>N<sub>2</sub>O<sub>18</sub>P<sub>2</sub></td><td>UDP-glucuronic acid</td></tr><tr><td>14</td><td>606.06</td><td>384.9445, 402.996, 282.045, 272.956, 323.038, 305.017, 362.008</td><td>C<sub><sc>17</sc></sub>H<sub>27</sub>N<sub>3</sub>O<sub>17</sub>P<sub>2</sub></td><td>UDP-GlcNAc (UDP-HexNAc)</td></tr><tr><td>15</td><td>611.14</td><td>306.071, 272.086, 338.058, 254.079, 482.103, 304.058, 288.058, 593.121</td><td>C<sub><sc>20</sc></sub>H<sub>32</sub>N<sub>6</sub>O<sub>12</sub>S<sub>2</sub></td><td>Glutathione, oxidized (GSSG)</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec13"><title>Intralobular distributions of metabolites in the liver</title><p>Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> shows the tissue distribution of metabolites in the control fed liver of NOG mice. As seen in Figs.&#x000a0;<xref rid="Fig2" ref-type="fig">2a and b</xref>, by use of Masson trichrome staining we were able to distinguish portal and central venules by judging the presence of bile ducts as a typical structure of the portal triad. Worthy of note is that the intraluminal space of the portal (P) and central venules indicated strong signals of 2,3-BPG (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2d</xref>) whereas taurocholate, the taurine-conjugated form of cholic acid, was evident in bile ducts (B) adjacent to the portal venules and periportal parenchyma, showing a typical P&#x02013;P bridging pattern (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2e</xref>). On the other hand, UDP-glucuronate, a substrate for glucuronidization of xenobiotic compounds was localized mainly in pericentral regions, with a pattern distinct from that of taurocholate (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2f</xref>). Such an intralobular microanatomical relationship among periportal and pericentral regions and the microvessels was well demonstrated by superimposition of taurocholate (<italic>m</italic>/<italic>z</italic> 514.28; green in Figs.&#x000a0;<xref rid="Fig2" ref-type="fig">2g and h</xref>) with 2,3-BPG (<italic>m</italic>/<italic>z</italic> 264.95; red in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2g</xref>) or UDP-glucuronate (<italic>m</italic>/<italic>z</italic> 579.03; red in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2h</xref>), respectively. In contrast, an intralobular pattern of UDP-HexNAc was distinct, distributing homogeneously over the whole liver parenchyma (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2i</xref>). These results suggest that several different metabolites such as 2,3-BPG, taurocholate, and UDP-glucuronate visualized by use of this method serve as reliable markers to distinguish vascular structures and periportal and pericentral regions in hepatic zonation. Such results were also consistent with previous observations as follows. First, 2,3-BPG occurs abundantly in red blood cells, being at approximately 5&#x000a0;mmol&#x000a0;L<sup>&#x02212;1</sup> [<xref ref-type="bibr" rid="CR23">23</xref>]. Secondly, taurocholate is synthesized and excreted to bile canaliculi around periportal hepatocytes [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], whereas UDP-glucuronate is biosynthesized predominantly in pericentral hepatocytes, which had a large capacity for xenobiotic detoxification [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Our approach to analysis of metabolites at the microscopic level, serves as a powerful tool to investigate intralobular heterogeneity in metabolic systems in the liver.
<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>In situ mass spectrometric imaging of metabolites in the control liver of an NOG mouse. <bold>a</bold> An optical image of a section stained with Masson&#x02019;s trichrome solutions. The stained section was adjacent to that was used for IMS. <italic>Scale bar</italic>: 500&#x000a0;&#x003bc;m, <italic>B</italic>&#x02009;:&#x02009;bile duct, <italic>P</italic>&#x02009;:&#x02009;portal venule. <bold>b</bold> the image with greater magnification of the area indicated by the <italic>white square</italic> in <bold>a</bold>. Collagen fibers in the portal triad were stained in blue. <italic>B</italic>&#x02009;:&#x02009;bile duct, <italic>P</italic>&#x02009;:&#x02009;portal venule. <bold>c</bold> Light-microscopic image of frozen liver section used in mass spectrometric imaging that was captured before matrix application. <italic>Scale bar</italic>: 500&#x000a0;&#x003bc;m. <bold>d</bold> An ion image of 2,3-bisphosphoglycerate (2,3-BPG) at <italic>m</italic>/<italic>z</italic>&#x02009;=&#x02009;264.95 and <bold>e</bold> taurocholate at <italic>m</italic>/<italic>z</italic>&#x02009;=&#x02009;514.28, <bold>f</bold> UDP-glucuronate at <italic>m</italic>/<italic>z</italic>&#x02009;=&#x02009;579.03. <bold>g</bold> The overlaid image of 2,3-BPG (<italic>red</italic>) and taurocholate (<italic>green</italic>). <bold>h</bold> UDP-glucuronate (<italic>red</italic>) and taurocholate (<italic>green</italic>). <bold>i</bold> UDP-HexNAc at <italic>m</italic>/<italic>z</italic>&#x02009;=&#x02009;606.06. A representative set of pictures from four separate experiments</p></caption><graphic xlink:href="216_2011_4895_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec14"><title>Distinct properties of energy metabolism between cancer metastases and liver parenchyma</title><p>Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> shows representative pictures of high-energy adenylate phosphates in liver bearing colon cancer metastases under fed conditions. As seen in Figs.&#x000a0;<xref rid="Fig3" ref-type="fig">3a and b</xref>, the micrometastases were clearly identified by green fluorescence generated by <italic>venus</italic>-expressing HCT116 cells. Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3c</xref> depicts mapping of apparent energy charge that was calculated from images of AMP, ADP, and ATP (Figs.&#x000a0;<xref rid="Fig3" ref-type="fig">3d, e, and f</xref>, respectively). Worthy of note was that intralobular distribution of these three adenylates appeared almost homogeneous, whereas the energy charge composed from these images had a heterogeneous pattern, being greater at the sites of cancer metastasis than in the liver parenchyma. So far as judged from the intensities, the apparent energy charge in the metastatic foci was approximately 0.8, while that in the parenchyma was 0.5&#x02013;0.7, suggesting that the foci accelerate generation of high-energy adenylate phosphates. Of importance were semiquantitative values of [ATP]<sub>app</sub> in the tumor-bearing liver (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3f</xref>), in the range of approximately 1&#x02013;2&#x000a0;&#x003bc;mol&#x000a0;g<sup>&#x02212;1</sup> liver, levels reasonably comparable with previous observations that determined absolute ATP contents under the snap-frozen procedures [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Because intracellular levels of ATP are in the mmol&#x000a0;L<sup>&#x02212;1</sup> range, current procedures for data calibration seemed to reproduce reliable intracellular concentrations of metabolites with a rapid turnover.
<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Representative pictures indicating high-energy adenylate phosphates and apparent energy charge in the tumor-bearing livers of NOG mice. <bold>a</bold> A light-microscopic photograph of intrasplenically injected HCT116 colon cancer cell xenografts. <italic>Scale bar</italic>: 500&#x000a0;&#x003bc;m. <bold>b</bold> A green fluorescence image of the same region shown in (<bold>a</bold>). <italic>Scale bar</italic>: 500&#x000a0;&#x003bc;m. <bold>c</bold> A heat map of apparent energy charge calculated from apparent contents of tumor bearing-liver. <bold>d</bold>&#x02013;<bold>f</bold> Heat maps of [AMP]<sub>app</sub>, [ADP]<sub>app</sub>, and [ATP]<sub>app</sub>, respectively. A representative set of pictures from four separate experiments</p></caption><graphic xlink:href="216_2011_4895_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec15"><title>Glutathione and UDP-HexNAc serve as marker metabolites enriched in the cancer xenografts</title><p>Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> shows representative pictures of UDP-HexNAc, reduced (GSH), and oxidized (GSSG) forms of glutathione. As seen in Figs.&#x000a0;<xref rid="Fig4" ref-type="fig">4a&#x02013;c</xref>, UDP-HexNAc was predominantly high in the tumor metastases. GSH and GSSG signals were also greater in the metastatic foci, but with a different pattern from that of UDP-HexNAc (Figs.&#x000a0;<xref rid="Fig4" ref-type="fig">4d&#x02013;f</xref>). When focusing on individual foci, UDP-HexNAc and GSH seemed to be demarcated from each other, suggesting these molecules occur in a spatially heterogeneous manner in an individual metastatic focus.
<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Glutathione and UDP-HexNAc as marker metabolites enriched in hepatic cancer metastasis. <bold>a</bold> Light-microscopic photograph of intrasplenically injected HCT116 colon cancer cell xenografts in the liver of NOG mice. <italic>Scale bar</italic>: 500&#x000a0;&#x003bc;m. <bold>b</bold> A green fluorescence image of the same specimen shown in (<bold>a</bold>). <italic>Scale bar</italic>: 500&#x000a0;&#x003bc;m. <bold>c</bold> An apparent contents map of UDP-HexNAc at <italic>m</italic>/<italic>z</italic> 606.06. <bold>d</bold>, <bold>e</bold> Apparent contents maps of the reduced type of glutathione (GSH) at <italic>m</italic>/<italic>z</italic> 306.07, and oxidized glutathione (GSSG) at <italic>m</italic>/<italic>z</italic> 611.14. <bold>f</bold> [GSH]<sub>app</sub>/[GSSG]<sub>app</sub> ratio imaging in the same microscopic field plotted as a heat map. A representative set of pictures from four separate experiments</p></caption><graphic xlink:href="216_2011_4895_Fig4_HTML" id="MO4"/></fig></p><p>Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> illustrates semiquantitative comparison of these metabolites among different groups. As seen in Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a</xref> showing data collected from CE&#x02013;MS, amounts of UDP-HexNAc in the tumor-bearing liver (tumor plus liver) were significantly greater than those in the control liver. On the other hand, amounts of GSH and GSSG were not significantly different between the groups. When MALDI&#x02013;MS intensity ratios in IMS for these metabolites were analyzed (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5b</xref>), UDP-HexNAc, GSH, and GSSG were significantly elevated in the metastatic foci compared with those measured in the hepatic parenchyma. Such a trend was reproducible in the calibrated data showing apparent contents of these metabolites (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5c</xref>), suggesting that both forms of glutathione occurred prominently in the metastatic foci to greater extents than in the host liver parenchyma.
<fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Differences in contents of UDP-HexNAc, and reduced (<italic>GSH</italic>) and oxidized (<italic>GSSG</italic>) glutathione in the tumor-bearing-NOG liver. <bold>a</bold> Differences in CE&#x02013;MS data between the control (<italic>open columns</italic>) and the tumor-bearing livers (<italic>dark columns</italic>) of NOG mice. <bold>b</bold> The MALDI&#x02013;MS signal intensity ratio of UDP-HexNAc, GSH, and GSSG in the parenchyma (<italic>P; open columns</italic>) and metastatic foci (<italic>M; closed columns</italic>) versus the average MALDI&#x02013;MS intensity of the ROIs as a whole. <italic>Bars</italic> indicate SD. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 according to Mann&#x02013;Whitney <italic>U</italic>-tests. <bold>c</bold> Apparent amounts of UDP-HexNAc, GSH, and GSSG in the parenchyma (<italic>P; open columns</italic>) and metastatic foci (<italic>M; closed columns</italic>). <italic>Bars</italic> indicate SD from four separate experiments. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, Mann&#x02013;Whitney <italic>U</italic>-tests</p></caption><graphic xlink:href="216_2011_4895_Fig5_HTML" id="MO5"/></fig></p><p>In the control liver, UDP-HexNAc which is an important substrate for polysaccharide chains including hyaluronic acid, was homogeneously distributed over the liver (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2i</xref>). As seen in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>, on the other hand, the colon cancer xenografts exhibited greater accumulation than the liver parenchyma. Ishimoto et al. and our laboratory have recently provided evidence that CD44, the hyaluronic acid receptor expressed on cancer stem cells, is responsible for stabilization of the cystine transporter xCT that accelerates uptake of cysteine and glutathione to increase their anti-oxidative capacity against cell death [<xref ref-type="bibr" rid="CR28">28</xref>]. Because GSH detoxifies electrophiles through their conjugation by glutathione <italic>S</italic>-transferases, such accumulation of the thiol might contribute to survival of the cancer cells against anti-cancer reagents [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Up to now, it remains still difficult to visualize amino acids globally by MALDI&#x02013;MS with high spatial resolution. Improvement of the spatial resolution in the current IMS system together with development of the method to visualize amino acid metabolism deserves further studies provided that resources and mechanisms for delivery of amino acids to maintain GSH in cancer cells are revealed.</p></sec></sec><sec id="Sec16"><title>Conclusion</title><p>Comparison of differences in metabolomic profiles between control livers and those bearing metastatic foci of the human colon cancer enabled us to reveal distinct metabolic features between the two regions. IMS using 9-aminoacridine enabled us to detect nucleotides, lipids, and several aminosugars. The metastatic human colon cancer xenografts displayed remarkable accumulation of UDP-HexNAc and glutathione in vivo, serving as marker metabolites. Newly developed IMS combined with CE&#x02013;MS measurements serves as a potentially reliable method to perform intergroup comparison of varied metabolites among different tissue specimens. Future investigation is necessary to establish methodology for use of the current technique in diagnostic medicine.</p></sec><sec sec-type="supplementary-material"><sec id="AppESM1"><title>Electronic supplementary material</title><supplementary-material id="d28e1819" content-type="local-data"><p>Below is the link to the electronic supplementary material.
</p><media xlink:href="216_2011_4895_MOESM1_ESM.pdf" id="MOESM1" mimetype="application" mime-subtype="pdf"><label>ESM 1</label><caption><p>(PDF 182 kb)</p></caption></media></supplementary-material></sec></sec></body><back><ack><title>Acknowledgements</title><p>The authors are grateful to Masaaki Matsuura (Japan Federation of Cancer Research) and all the member of the SENTAN project (Shimadzu Corporation), Kenji Kawai (Central Institute for Experimental Animals), and members of Suematsu Laboratory for providing considerable support for our research. The authors acknowledge support for this work by a Grant-in-Aid for SENTAN from the Japan Science and Technology Agency (to M.Se. and M.W) and from the JST ERATO Suematsu Gas Biology Project (to M.Su). Design of CE&#x02013;MS-based metabolome analysis in this study was supported by Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of MEXT.</p><p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiura</surname><given-names>Y</given-names></name><name><surname>Konishi</surname><given-names>Y</given-names></name><name><surname>Zaima</surname><given-names>N</given-names></name><name><surname>Kajihara</surname><given-names>S</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name><name><surname>Taguchi</surname><given-names>R</given-names></name><name><surname>Setou</surname><given-names>M</given-names></name></person-group><article-title>Visualization of the cell-selective distribution of PUFA-containing phosphatidylcholines in mouse brain by imaging mass spectrometry</article-title><source>J Lipid Res</source><year>2009</year><volume>50</volume><fpage>1776</fpage><lpage>1788</lpage><pub-id pub-id-type="doi">10.1194/jlr.M900047-JLR200</pub-id><pub-id pub-id-type="pmid">19417221</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimma</surname><given-names>S</given-names></name><name><surname>Sugiura</surname><given-names>Y</given-names></name><name><surname>Hayasaka</surname><given-names>T</given-names></name><name><surname>Zaima</surname><given-names>N</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Setou</surname><given-names>M</given-names></name></person-group><article-title>Mass imaging and identification of biomolecules with MALDI&#x02013;QIT-TOF-based system</article-title><source>Anal Chem</source><year>2008</year><volume>80</volume><fpage>878</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.1021/ac071301v</pub-id><pub-id pub-id-type="pmid">18166020</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khatib-Shahidi</surname><given-names>S</given-names></name><name><surname>Andersson</surname><given-names>M</given-names></name><name><surname>Herman</surname><given-names>JL</given-names></name><name><surname>Gillespie</surname><given-names>TA</given-names></name><name><surname>Caprioli</surname><given-names>RM</given-names></name></person-group><article-title>Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry</article-title><source>Anal Chem</source><year>2006</year><volume>78</volume><fpage>6448</fpage><lpage>6456</lpage><pub-id pub-id-type="doi">10.1021/ac060788p</pub-id><pub-id pub-id-type="pmid">16970320</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoeckli</surname><given-names>M</given-names></name><name><surname>Chaurand</surname><given-names>P</given-names></name><name><surname>Hallahan</surname><given-names>DE</given-names></name><name><surname>Caprioli</surname><given-names>RM</given-names></name></person-group><article-title>Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues</article-title><source>Nat Med</source><year>2001</year><volume>7</volume><fpage>493</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1038/86573</pub-id><pub-id pub-id-type="pmid">11283679</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groseclose</surname><given-names>MR</given-names></name><name><surname>Andersson</surname><given-names>M</given-names></name><name><surname>Hardesty</surname><given-names>WM</given-names></name><name><surname>Caprioli</surname><given-names>RM</given-names></name></person-group><article-title>Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry</article-title><source>J Mass Spectrom</source><year>2007</year><volume>42</volume><fpage>254</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1002/jms.1177</pub-id><pub-id pub-id-type="pmid">17230433</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>JL</given-names></name><name><surname>Kennedy</surname><given-names>RT</given-names></name></person-group><article-title>Metabolomic analysis of eukaryotic tissue and prokaryotes using negative mode MALDI time-of-flight mass spectrometry</article-title><source>Anal Chem</source><year>2005</year><volume>77</volume><fpage>2201</fpage><lpage>2209</lpage><pub-id pub-id-type="doi">10.1021/ac048323r</pub-id><pub-id pub-id-type="pmid">15801754</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Kajimura</surname><given-names>M</given-names></name><name><surname>Hishiki</surname><given-names>T</given-names></name><name><surname>Nakanishi</surname><given-names>T</given-names></name><name><surname>Kubo</surname><given-names>A</given-names></name><name><surname>Nagahata</surname><given-names>Y</given-names></name><name><surname>Ohmura</surname><given-names>M</given-names></name><name><surname>Yachie-Kinoshita</surname><given-names>A</given-names></name><name><surname>Matsuura</surname><given-names>T</given-names></name><name><surname>Morikawa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Paradoxical ATP elevation in ischemic penumbra revealed by quantitative imaging mass spectrometry</article-title><source>Antioxid Redox Signal</source><year>2010</year><volume>13</volume><fpage>1157</fpage><lpage>1167</lpage><pub-id pub-id-type="doi">10.1089/ars.2010.3290</pub-id><pub-id pub-id-type="pmid">20486758</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Miura D, Fujimura Y, Yamato M, Hyodo F, Utsumi H, Tachibana H, Wariishi H (2010) Ultrahighly sensitive in situ metabolomic imaging for visualizing spatiotemporal metabolic behaviors. Anal Chem 82:9789&#x02013;9796</mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname><given-names>T</given-names></name><name><surname>Yuba-Kubo</surname><given-names>A</given-names></name><name><surname>Sugiura</surname><given-names>Y</given-names></name><name><surname>Zaima</surname><given-names>N</given-names></name><name><surname>Hayasaka</surname><given-names>T</given-names></name><name><surname>Goto-Inoue</surname><given-names>N</given-names></name><name><surname>Wakui</surname><given-names>M</given-names></name><name><surname>Suematsu</surname><given-names>M</given-names></name><name><surname>Takeshita</surname><given-names>K</given-names></name><name><surname>Ogawa</surname><given-names>K</given-names></name><etal/></person-group><article-title>Visualization of volatile substances in different organelles with an atmospheric-pressure mass microscope</article-title><source>Anal Chem</source><year>2009</year><volume>81</volume><fpage>9153</fpage><lpage>9157</lpage><pub-id pub-id-type="doi">10.1021/ac901872n</pub-id><pub-id pub-id-type="pmid">19788281</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooks</surname><given-names>RG</given-names></name><name><surname>Ouyang</surname><given-names>Z</given-names></name><name><surname>Takats</surname><given-names>Z</given-names></name><name><surname>Wiseman</surname><given-names>JM</given-names></name></person-group><article-title>Detection Technologies. Ambient mass spectrometry</article-title><source>Science</source><year>2006</year><volume>311</volume><fpage>1566</fpage><lpage>1570</lpage><pub-id pub-id-type="doi">10.1126/science.1119426</pub-id><pub-id pub-id-type="pmid">16543450</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>L</given-names></name></person-group><article-title>Mass spectrometry imaging of small molecules using desorption/ionization on silicon</article-title><source>Anal Chem</source><year>2007</year><volume>79</volume><fpage>3535</fpage><lpage>3541</lpage><pub-id pub-id-type="doi">10.1021/ac0611465</pub-id><pub-id pub-id-type="pmid">17428031</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemes</surname><given-names>P</given-names></name><name><surname>Barton</surname><given-names>AA</given-names></name><name><surname>Vertes</surname><given-names>A</given-names></name></person-group><article-title>Three-dimensional imaging of metabolites in tissues under ambient conditions by laser ablation electrospray ionization mass spectrometry</article-title><source>Anal Chem</source><year>2009</year><volume>81</volume><fpage>6668</fpage><lpage>6675</lpage><pub-id pub-id-type="doi">10.1021/ac900745e</pub-id><pub-id pub-id-type="pmid">19572562</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Shrestha</surname><given-names>B</given-names></name><name><surname>Vertes</surname><given-names>A</given-names></name></person-group><article-title>Atmospheric pressure infrared MALDI imaging mass spectrometry for plant metabolomics</article-title><source>Anal Chem</source><year>2008</year><volume>80</volume><fpage>407</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1021/ac701703f</pub-id><pub-id pub-id-type="pmid">18088102</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sroyraya</surname><given-names>M</given-names></name><name><surname>Goto-Inoue</surname><given-names>N</given-names></name><name><surname>Zaima</surname><given-names>N</given-names></name><name><surname>Hayasaka</surname><given-names>T</given-names></name><name><surname>Chansela</surname><given-names>P</given-names></name><name><surname>Tanasawet</surname><given-names>S</given-names></name><name><surname>Shrivas</surname><given-names>K</given-names></name><name><surname>Sobhon</surname><given-names>P</given-names></name><name><surname>Setou</surname><given-names>M</given-names></name></person-group><article-title>Visualization of biomolecules in the eyestalk of the blue swimming crab, <italic>Portunus pelagicus</italic>, by imaging mass spectrometry using the atmospheric-pressure mass microscope</article-title><source>Surf Interface Anal</source><year>2010</year><volume>42</volume><fpage>1589</fpage><lpage>1592</lpage><pub-id pub-id-type="doi">10.1002/sia.3571</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takizawa</surname><given-names>Y</given-names></name><name><surname>Mizuta</surname><given-names>K</given-names></name><name><surname>Hayasaka</surname><given-names>T</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name><name><surname>Okamura</surname><given-names>J</given-names></name><name><surname>Mineta</surname><given-names>H</given-names></name><name><surname>Setou</surname><given-names>M</given-names></name></person-group><article-title>Specific localization of five phosphatidylcholine species in the cochlea by mass microscopy</article-title><source>Audiol Neurootol</source><year>2010</year><volume>16</volume><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">21160178</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Guan</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Gross</surname><given-names>RW</given-names></name></person-group><article-title>Shotgun metabolomics approach for the analysis of negatively charged water-soluble cellular metabolites from mouse heart tissue</article-title><source>Anal Chem</source><year>2007</year><volume>79</volume><fpage>6629</fpage><lpage>6640</lpage><pub-id pub-id-type="doi">10.1021/ac070843+</pub-id><pub-id pub-id-type="pmid">17665876</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamada</surname><given-names>K</given-names></name><name><surname>Monnai</surname><given-names>M</given-names></name><name><surname>Kawai</surname><given-names>K</given-names></name><name><surname>Nishime</surname><given-names>C</given-names></name><name><surname>Kito</surname><given-names>C</given-names></name><name><surname>Miyazaki</surname><given-names>N</given-names></name><name><surname>Ohnishi</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Suemizu</surname><given-names>H</given-names></name></person-group><article-title>Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice</article-title><source>Int J Oncol</source><year>2008</year><volume>32</volume><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">18097554</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Hiramatsu</surname><given-names>H</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Suzue</surname><given-names>K</given-names></name><name><surname>Kawahata</surname><given-names>M</given-names></name><name><surname>Hioki</surname><given-names>K</given-names></name><name><surname>Ueyama</surname><given-names>Y</given-names></name><name><surname>Koyanagi</surname><given-names>Y</given-names></name><name><surname>Sugamura</surname><given-names>K</given-names></name><name><surname>Tsuji</surname><given-names>K</given-names></name><etal/></person-group><article-title>NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells</article-title><source>Blood</source><year>2002</year><volume>100</volume><fpage>3175</fpage><lpage>3182</lpage><pub-id pub-id-type="doi">10.1182/blood-2001-12-0207</pub-id><pub-id pub-id-type="pmid">12384415</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handa</surname><given-names>K</given-names></name><name><surname>Ohmura</surname><given-names>M</given-names></name><name><surname>Nishime</surname><given-names>C</given-names></name><name><surname>Hishiki</surname><given-names>T</given-names></name><name><surname>Nagahata</surname><given-names>Y</given-names></name><name><surname>Kawai</surname><given-names>K</given-names></name><name><surname>Suemizu</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Wakui</surname><given-names>M</given-names></name><name><surname>Kitagawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Phosphorescence-assisted microvascular O(2) measurements reveal alterations of oxygen demand in human metastatic colon cancer in the liver of superimmunodeficient NOG mice</article-title><source>Adv Exp Med Biol</source><year>2010</year><volume>662</volume><fpage>423</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1007/978-1-4419-1241-1_61</pub-id><pub-id pub-id-type="pmid">20204825</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakuragawa</surname><given-names>T</given-names></name><name><surname>Hishiki</surname><given-names>T</given-names></name><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Ikeda</surname><given-names>S</given-names></name><name><surname>Soga</surname><given-names>T</given-names></name><name><surname>Yachie-Kinoshita</surname><given-names>A</given-names></name><name><surname>Kajimura</surname><given-names>M</given-names></name><name><surname>Suematsu</surname><given-names>M</given-names></name></person-group><article-title>Hypotaurine is an energy-saving hepatoprotective compound against ischemia&#x02013;reperfusion injury of the rat liver</article-title><source>J Clin Biochem Nutr</source><year>2010</year><volume>46</volume><fpage>126</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.3164/jcbn.09-91</pub-id><pub-id pub-id-type="pmid">20216945</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shintani</surname><given-names>T</given-names></name><name><surname>Iwabuchi</surname><given-names>T</given-names></name><name><surname>Soga</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Takano</surname><given-names>N</given-names></name><name><surname>Hishiki</surname><given-names>T</given-names></name><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Ikeda</surname><given-names>S</given-names></name><name><surname>Sakuragawa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Cystathionine beta-synthase as a carbon monoxide-sensitive regulator of bile excretion</article-title><source>Hepatology</source><year>2009</year><volume>49</volume><fpage>141</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1002/hep.22604</pub-id><pub-id pub-id-type="pmid">19085910</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soga</surname><given-names>T</given-names></name><name><surname>Baran</surname><given-names>R</given-names></name><name><surname>Suematsu</surname><given-names>M</given-names></name><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Ikeda</surname><given-names>S</given-names></name><name><surname>Sakurakawa</surname><given-names>T</given-names></name><name><surname>Kakazu</surname><given-names>Y</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Robert</surname><given-names>M</given-names></name><name><surname>Nishioka</surname><given-names>T</given-names></name><etal/></person-group><article-title>Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>16768</fpage><lpage>16776</lpage><pub-id pub-id-type="doi">10.1074/jbc.M601876200</pub-id><pub-id pub-id-type="pmid">16608839</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinoshita</surname><given-names>A</given-names></name><name><surname>Tsukada</surname><given-names>K</given-names></name><name><surname>Soga</surname><given-names>T</given-names></name><name><surname>Hishiki</surname><given-names>T</given-names></name><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Nakayama</surname><given-names>Y</given-names></name><name><surname>Tomita</surname><given-names>M</given-names></name><name><surname>Suematsu</surname><given-names>M</given-names></name></person-group><article-title>Roles of hemoglobin Allostery in hypoxia-induced metabolic alterations in erythrocytes: simulation and its verification by metabolome analysis</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>10731</fpage><lpage>10741</lpage><pub-id pub-id-type="doi">10.1074/jbc.M610717200</pub-id><pub-id pub-id-type="pmid">17289676</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Accatino</surname><given-names>L</given-names></name><name><surname>Simon</surname><given-names>FR</given-names></name></person-group><article-title>Identification and characterization of a bile acid receptor in isolated liver surface membranes</article-title><source>J Clin Invest</source><year>1976</year><volume>57</volume><fpage>496</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1172/JCI108302</pub-id><pub-id pub-id-type="pmid">3520</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahl</surname><given-names>E</given-names></name><name><surname>Arnesjo</surname><given-names>B</given-names></name></person-group><article-title>Taurocholate metabolism in man</article-title><source>Scand J Gastroenterol</source><year>1972</year><volume>7</volume><fpage>559</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.3109/00365527209180957</pub-id><pub-id pub-id-type="pmid">4634621</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacifici</surname><given-names>GM</given-names></name><name><surname>Rane</surname><given-names>A</given-names></name></person-group><article-title>Distribution of UDP-glucuronyltransferase in different human foetal tissues</article-title><source>Br J Clin Pharmacol</source><year>1982</year><volume>13</volume><fpage>732</fpage><lpage>735</lpage><pub-id pub-id-type="pmid">6805493</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suematsu</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name><name><surname>Ishii</surname><given-names>H</given-names></name><name><surname>Asako</surname><given-names>H</given-names></name><name><surname>Yanagisawa</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Oshio</surname><given-names>C</given-names></name><name><surname>Tsuchiya</surname><given-names>M</given-names></name></person-group><article-title>Intralobular heterogeneity of carbon tetrachloride-induced oxidative stress in perfused rat liver visualized by digital imaging fluorescence microscopy</article-title><source>Lab Invest</source><year>1991</year><volume>64</volume><fpage>167</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">1997731</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Yagi H, Masuko T, et al. (2011) CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc- and thereby promotes tumor growth. Cancer Cell 19:387&#x02013;400</mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moscow</surname><given-names>JA</given-names></name><name><surname>Fairchild</surname><given-names>CR</given-names></name><name><surname>Madden</surname><given-names>MJ</given-names></name><name><surname>Ransom</surname><given-names>DT</given-names></name><name><surname>Wieand</surname><given-names>HS</given-names></name><name><surname>O'Brien</surname><given-names>EE</given-names></name><name><surname>Poplack</surname><given-names>DG</given-names></name><name><surname>Cossman</surname><given-names>J</given-names></name><name><surname>Myers</surname><given-names>CE</given-names></name><name><surname>Cowan</surname><given-names>KH</given-names></name></person-group><article-title>Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors</article-title><source>Cancer Res</source><year>1989</year><volume>49</volume><fpage>1422</fpage><lpage>1428</lpage><pub-id pub-id-type="pmid">2466554</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dang</surname><given-names>DT</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Kohli</surname><given-names>M</given-names></name><name><surname>Rago</surname><given-names>C</given-names></name><name><surname>Cummins</surname><given-names>JM</given-names></name><name><surname>Dang</surname><given-names>LH</given-names></name></person-group><article-title>Glutathione S-transferase pi1 promotes tumorigenicity in HCT116 human colon cancer cells</article-title><source>Cancer Res</source><year>2005</year><volume>65</volume><fpage>9485</fpage><lpage>9494</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-1930</pub-id><pub-id pub-id-type="pmid">16230413</pub-id></mixed-citation></ref></ref-list><glossary><title>Abbreviations</title><def-list><def-list><def-item><term>CE&#x02013;MS</term><def><p>capillary electrophoresis&#x02013;mass spectrometry</p></def></def-item><def-item><term>MALDI</term><def><p>matrix assisted laser desorption/ionization</p></def></def-item></def-list></def-list></glossary><fn-group><fn><p>The first two authors equally contributed to this work.</p></fn></fn-group></back></article>